Sign In
Buy AYTU
$2.09
-0.0100 (-0.476%)
At Close: Jun 03, 2026
ENGLEWOOD, CO / ACCESSWIRE / May 12, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, annou
Aytu BioPharma to Report Third Quarter Fiscal 2021 Results on May 17, 2021
04:01pm, Monday, 10'th May 2021
ENGLEWOOD, CO / ACCESSWIRE / May 10, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, annou
Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics
08:00am, Monday, 12'th Apr 2021
Aytu gains global license to pivotal study-ready protein kinase C β isoform (PKCβ) inhibitor, AR101 (enzastaurin) in rare disease indications Program initially targeting vascular Ehlers-Danlos Syndr
5 Stocks to Buy on New Analyst Coverage
09:06am, Wednesday, 07'th Apr 2021
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Interactive Brokers (IBKR), Avid (CDMO), Oncternal (ONCT), Amtech (ASYS) and Aytu.
Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial Officer
08:00am, Monday, 05'th Apr 2021
ENGLEWOOD, CO / ACCESSWIRE / April 5, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, toda
Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma
07:30am, Thursday, 01'st Apr 2021
Strategic Transaction Provides $7.5M in Non-Dilutive Capital and Enables Pediatric and ADHD Product Focus Following the Recently Closed Merger with Neos Therapeutics ENGLEWOOD, CO / ACCESSWIRE / April
10 Reddit Penny Stocks Seeing the Most Chatter Today
01:46pm, Monday, 22'nd Mar 2021
Reddit penny stocks continue to be of interest to risky investors and InvestorPlace is looking at the top ones for Monday. The post 10 Reddit Penny Stocks Seeing the Most Chatter Today appeared first
Aytu BioScience Announces Close of Merger with Neos Therapeutics
06:00am, Monday, 22'nd Mar 2021
$100M revenue specialty pharmaceutical company on an accelerated path to profitability[1] Company name change to Aytu BioPharma, Inc. becomes effective today Former Neos Therapeutics board members Bet
Why Did Aytu Biosciences Gap Up Today? Technical Levels To Watch
05:34pm, Thursday, 18'th Mar 2021
Aytu Biosciences Inc. (NASDAQ: AYTU) shares gapped up Thursday morning. The price jump is speculatively from the meetings the company is having about the proposed merger with Neos Therapeutics Inc. (N
Merger News: Why NEOS Stock and AYTU Stock Are Climbing Today
08:37am, Thursday, 18'th Mar 2021
NEOS stock holders will get AYTU stock in this no-cash merger transaction. Today's vote has the support of two proxy advisory firms.
Why Are Neos Therapeutics, Aytu BioScience Stocks Soaring Today?
06:22am, Thursday, 18'th Mar 2021
Neos Therapeutics Inc (NASDAQ: NEOS) and Aytu BioScience Inc (NASDAQ: AYTU) shares are rising today in the premarket session, though there is no news on both companies. The investors are reacting
Aytu Bioscience, Inc. (AYTU) Moves 9.2% Higher: Will This Strength Last?
08:44am, Friday, 12'th Mar 2021
Aytu Bioscience, Inc. (AYTU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near
Aytu BioScience Stock Is Trading Higher After Healight Therapy Shows Improved Outcome In COVID-19 Patients
06:11am, Tuesday, 09'th Mar 2021
Aytu BioScience Inc (NASDAQ: AYTU) rises sharply in the premarket after first-in-human data with endotracheal UVA light catheter therapy show positive outcome in SARS-CoV-2 patients. Known as Hea
AYTU Stock Price Increases Over 15% Pre-Market: Why It Happened
06:04am, Tuesday, 09'th Mar 2021
The stock price of Aytu Bioscience Inc (NASDAQ: AYTU) increased by over 15% pre-market. This is why it happened.
Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 Patients
04:01pm, Monday, 08'th Mar 2021
Data indicate endotracheal UVA light catheter therapy reduces SARS-CoV-2 viral load and improves clinical outcomes in mechanically ventilated SARS-CoV-2 patients ENGLEWOOD, CO / ACCESSWIRE / March 8
